Indaptus Therapeutics Stock (NASDAQ: INDP) stock price, news, charts, stock research, profile.
Open | $1.59 |
Close | $1.63 |
Volume / Avg. | 9.22K / 20.74K |
Day Range | $1.59 - $1.72 |
52 Wk Range | 1.56 - 4.08 |
Market Cap | $16.82M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 0.11% |
Days to Cover | 1.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Indaptus Therapeutics (NASDAQ:INDP) through any online brokerage.
Other companies in Indaptus Therapeutics’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Evaxion Biotech (NASDAQ:EVAX) and Sensei Biotherapeutics (NASDAQ:SNSE).
Indaptus Therapeutics has a consensus price target of $14.00.
The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $1.65 last updated August 22, 2024 at 8:00 AM EDT.
There are no upcoming dividends for Indaptus Therapeutics.
Indaptus Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Indaptus Therapeutics.
Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.